Fricker, L.D., Proteasome inhibitor drugs. Annual Review Pharmacology and Toxicology. in press, 2019.
Fritz R, Mukherjee A, Zaghi S, Agalliu I, Jindal S, Tashima AK, Fricker LD, Davies KP., Identification and characterization of RSIY-11, a novel seminal peptide derived from semenogelin-1, which acts as a neutral endopeptidase inhibitor modulating sperm motility. J Assist Reprod Genet. 2019. doi: 10.1007/s10815-019-01524-8.
Dasgupta S, Fishman MA, Castro LM, Tashima AK, Ferro ES, Fricker LD., Effect of protein denaturation and enzyme inhibitors on proteasomal-mediated production of peptides in Human Embryonic Kidney Cells. Biomolecules. 2019 May 28;9(6). pii: E207. doi: 10.3390/biom9060207.
Fricker L., Quantitative peptidomics: General considerations. Methods Mol Biol. 2018; 1719:121-140.
Fricker LD., Carboxypeptidase E and the identification of novel neuropeptides as potential therapeutic targets. Adv Pharmacol. 2018; 82:85-102.
Tashima AK, Fricker LD., Quantitative peptidomics with five-plex reductive methylation labels. J Am Soc Mass Spectrom. 2018; 29(5):866-878.
Fricker LD, Devi LA., Orphan neuropeptides and receptors: Novel therapeutic targets. Pharmacol Ther. 2018; 185:26-33.
Garcia-Pardo J, Tanco S, DÃaz L, Dasgupta S, Fernandez-Recio J, Lorenzo J, Aviles FX, Fricker LD., Substrate specificity of human metallocarboxypeptidase D: Comparison of the two active carboxypeptidase domains. PLoS One. 2017; 12(11):e0187778.
Berezniuk I, Rodriguiz RM, Zee ML, Marcus DJ, Pintar J, Morgan DJ, Wetsel WC, Fricker LD., ProSAAS-derived peptides are regulated by cocaine and are required for sensitization to the locomotor effects of cocaine. J Neurochem. 2017; 143(3):268-281.